Best of ASCO - 2014 Annual Meeting

 

Welcome

Other

Tumor Biology

2018 ASCO Annual Meeting

Sort by: title abstract no. first author
ABSTRACT TITLEFIRST AUTHORABSTRACT NO.
A comprehensive genomic analysis of squamous cell carcinomas of the lung, esophagus, and head and neck.

Lara Ann Kujtan

12123

Acquired BRAF fusions as a mechanism of resistance to EGFR therapy.

Morana Vojnic

12122

Are racial differences in obesity and insulin resistance related to aggressive breast cancer?

Emily Gallagher

12125

Assessment of the genomic stability and molecular landscape of patient-derived xenograft (PDX) models from NCI’s Patient-Derived Models Repository (PDMR).

Bishwajit Das

12023

Cancer-type dependent expression of CK2 transcripts.

Melissa Ming Jie Chua

e24333

CDK4/6 inhibitor and radiation therapy in malignant pleural mesothelioma.

Seiji Matsumoto

e24326

Comparative effectiveness of anti-diabetic drugs in morbidity and mortality of breast cancer in diabetic patients: A network meta-analysis.

Cong Dai

e24330

Could less apatnib be better? an exploration study of dose-effect of apatnib in 41 stage IV solid tumors.

Yingying Huang

e24328

Early mortality with immune checkpoint inhibitors (IOs) in solid tumors: An inconvenient truth?

Eric Winquist

12121

Evaluation of RNA Polymerase I Subunit C gene (POLR1C) as prognostic biomarker in cancer.

Junior Smith Torres-Roman

e24325

FDG-uptake and expression levels of TILs and PD-L1 in primary breast cancer.

Tomoko Hirakata

12119

Improving versatility of generating recombinant adenovirus.

Jason Hirshberg

e24321

Mass spectrometry biomolecular omics profiling and imaging to dissect the initial emergence of molecular drug resistance in ALK-positive (ALK+) lung cancer.

Xiaoliang Wu

12018

Modulating tumor-specific tissue penetration via peptides enhances the efficacy of radiotherapy.

Fanyan Meng

e24324

Molecular comparison of interval and screen-detected breast cancers.

Dane Anthony Cheasley

12124

Phenotypic characteristics of erythrocytes in patients with malignant and benign tumors.

Andrey A. Maslov

e24327

Radiation-induced pulmonary cellular senescence and the potential regulatory mechanism of lpa-LPA1 pathway.

Mengqian Li

e24332

Survival outcome of breast cancer (BC) patients presenting with recurrent and de novo isolated contralateral lymph node metastases (CLNM).

Aydah Al-Awadhi

12120

The association between blood lipid and breast cancer risk: Evidence based on a dose-response meta-analysis comprising 900,669 participants.

Kang Liu

e24331

Therapeutic pathomorphism of non-small cell lung cancer (NSCLC) as a result of neoadjuvant chemoimmunotherapy (nCIT) with tumor necrosis factor (TNFα1).

Yuri Lazutin

e24323

Tumor growth and regression rate constants from the CLARINET study as surrogate endpoints for progression free survival: A novel assessment approach in cancer therapy.

Clarisse Dromain

e24329

Whole exome sequencing (WES) to define the genomic landscape of young lung cancer patients (pts).

Xiaoliang Wu

12005